SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,028.02 1,718.01
( 2.17%)

Global Indices

Nasdaq

51,872.69 -1,504.43
(-2.82%)

Dow Jones

7,442.16 -267.46
(-3.47%)

Hang Seng

57,293.47 -3,784.43
(-6.20%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.59 -0.14
(-0.15%)

EUR-INR

106.30 0.31
(0.29%)

GBP-INR

127.42 0.36
(0.28%)

JPY-INR

0.60 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Alembic Pharmaceuticals consolidated net profit rises 81.46% in the September 2026 quarter

Nov 05,2026

Net profit of Alembic Pharmaceuticals rose 81.46% to Rs 335.17 crore in the quarter ended September 2026 as against Rs 184.71 crore during the previous quarter ended September 2025. Sales rose 36.30% to Rs 2603.48 crore in the quarter ended September 2026 as against Rs 1910.15 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	2603.48	1910.15	36
OPM %	21.58	16.53	-
PBDT	538.75	299.79	80
PBT	437.95	223.72	96
NP	335.17	184.71	81

81,028.02 1,718.01 ( 2.17%)

51,872.69 -1,504.43 (-2.82%)

7,442.16 -267.46 (-3.47%)

57,293.47 -3,784.43 (-6.20%)

10,662.59 -120.07 (-1.11%)

94.59 -0.14 (-0.15%)

106.30 0.31 (0.29%)

127.42 0.36 (0.28%)

0.60 0.00 (-0.15%)